Table 1.
Multivariate analysis for DFS and OS in patients with gliomas
| Factors | DFS | OS | ||
|---|---|---|---|---|
| HR (95% CI) | P | HR (95% CI) | P | |
| Gender | 0.882 (0.592‐1.316) | .5401 | 0.835 (0.559‐1.247) | .3772 |
| Age | 1.000 (0.984‐1.016) | .9762 | 1.007 (0.990‐1.025) | .4133 |
| Predominant side | 0.893 (0.605‐1.320) | .5713 | 0.929 (0.629‐1.371) | .7092 |
| Predominant location | 1.117 (0.821‐1.274) | .1092 | 1.119 (0.882‐1.440) | .3014 |
| KPS | 1.031 (0.504‐2.112) | .9334 | 1.013 (0.485‐2.113) | .9728 |
| WHO grade | 1.239 (1.199‐1.293) | <.0001 | 1.402 (1.388‐1.492) | <.0001 |
| IDH status | 0.135 (0.031‐0.580) | .0068 | 0.498 (0.297‐0.627) | .0207 |
| HMGA2 LI | 1.467 (1.125‐1.914) | .0047 | 1.571 (1.460‐1.718) | .0004 |
| MMP2 LI | 1.098 (0.857‐1.407) | .4583 | 1.019 (0.927‐1.114) | .6188 |
CI, confidence interval; HR, hazard ratio; LI, labeling index.